Introducing the Board of Directors

Venomtech are very excited and honoured to announce the formation of the Board of Directors combining decades of pharmaceutical, clinical and financial experience. Our founding board members represent a group of leaders who are strong advocates for the mission of the organisation. Bringing a wide range of experience and talents, the board is in the perfect position to lead Venomtech into the future of biotherapeutics. The founding members include:

Managing Director – Steven Trim. Founder of Venomtech Ltd. After 10 years in the pharmaceutical industry as a molecular biologist and safety delegate followed by a brief research associate position in a comparative genomics lab, Venomtech was established to meet the need for venom reagents in the UK. Venomtech now produce hit-to-tool, automation compatible biological libraries targeted to therapeutic areas to maximise hit potential.

Chairman – Dr Denis Henrard. With over 24 years’ experience as an international pharmaceutical business developer, Denis has made a significant impact in developing Venomtech’s research strategy to develop an intellectual property portfolio.

Financial Director – Clive Newell. Founder and Principal Director of Halagen Ltd (established in 2005) – a company providing experienced Finance Directors for businesses on a part-time basis. Halagen specialise in working with ambitious, high-growth SMEs who want assistance in making critical decisions for the development of their companies.

Scientific Advisor & Non Executive Director – Professor Karol Sikora. A world respected oncologist and campaigner for better universal cancer treatment. Internationally famous for his research into the behaviour of cancer cells and the use of gene therapy as treatment.